Examples of Inventorship Margin in a sentence
If a country accedes to the European Union and is incorporated into the collaboration pursuant to this Section 2.16 (Territorial Expansion), Ivory Net Revenues from sales of Ivory in such country will not be included within Ivory Net Revenues for the purpose of calculating the Inventorship Margin, but will be included in Ivory Net Revenues for all other purposes hereunder.
For this example, assume the following: Total Amgen Partner Net Revenues [*] [*] [*] Inventorship Margin [*] [*] [*] Share of Net Revenues [*] [*] [*] Collaboration Costs [*] [*] [*] True-Up Payment [*] [*] In such a case, each Party’s share of Net Revenues for Q3 2017 would still be [*], ([*]-[*] = [*] / [*] = [*]).
Each of the Parties acknowledges that the value provided by the other hereunder is comprised of many related items, including performance of various services, access to development and commercial expertise, clinical data and other financial and non-financial consideration and that the amount of the Inventorship Margin, and the ratio of profit and expense sharing set forth herein are intended to capture such value as an aggregate.
The total profit (or loss) for a calendar quarter will be calculated by Amgen by first deducting from Ivory Net Revenues for such quarter a percentage of such Ivory Net Revenues equal to the Inventorship Margin, which will be paid to Amgen to reflect Amgen’s inventorship of Ivory; and then deducting from the remaining Ivory Net Revenues the GSK Costs and Amgen Costs reported by the Parties pursuant to Sections 6.1.1 (GSK Costs) and 6.1.2 (Amgen Costs).
Assume for purposes of this example that Net Revenues for Q3 2017 are [*] and the Inventorship Margin is [*] (consistent with the example above).
Additionally, if Partner is the Continuing Party, Partner will pay to Amgen an additional royalty equal to the applicable Terminated Product Inventorship Margin on Terminated Product Net Revenues by Partner, its Affiliates and sublicensees.
Further assume the following for X0 0000: Total Amgen Partner Net Revenues [*] [*] [*] Inventorship Margin [*] [*] [*] Share of Net Revenues [*] [*] [*] Collaboration Costs [*] [*] [*] True-Up Payment [*] [*] In such a case, each Party’s share of Net Revenues for Q3 2017 would be [*] ([*]-[*] = [*] / [*] = [*]).
Each of the Parties acknowledges that the value provided by the other hereunder is comprised of many related items, including performance of various services, access to development, regulatory, manufacturing and commercial expertise, clinical data and other financial and non-financial consideration and that the amount of the Inventorship Margin, and the ratio of profit and expense sharing set forth herein are intended to capture such value as an aggregate.
The total profit for a calendar quarter will be calculated by Amgen by first deducting from aggregate Net Revenues for each Product for such quarter a percentage of such Net Revenues equal to the applicable “Inventorship Margin” set forth below, which will be paid to Amgen to reflect Amgen’s inventorship of the Products: Inventorship Margin AMG827 Other Products [*] [*] Additionally, [*].
Assume for purposes of this example that Net Revenues are as follows: Q1 2017 Q2 2017 Q3 2017 Q4 2017 Net Revenues (excluding AMG827): [*] [*] [*] [*] Net Revenues (AMG827 only): [*] [*] [*] [*] Taking the third quarter as a representative example, the Inventorship Margin would be calculated as follows: In X0 0000, quarterly Net Revenues (excluding AMG827) are [*] and quarterly Net Revenues (AMG827 only) are [*].